Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $78.00 Average Price Target from Analysts
Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have earned an average rating of “Buy” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have covered the stock in the […]
Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have earned an average rating of “Buy” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have covered the stock in the […]
